Parathyroid hormone-related protein and bone metastases

Cancer

Volumn 80, Issue 8 SUPPL., 1997, Pages 1572-1580

  Guise, Theresa A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone metastasis; Breast carcinoma; Hypercalcemia; Osteolysis; Parathyroid hormone related protein (PTH rP)

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; GLUCOCORTICOID; GROWTH FACTOR; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PARATHYROID HORMONE RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; BONE METASTASIS; BREAST CANCER; CANCER GROWTH; CONFERENCE PAPER; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; HYPERCALCEMIA; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0030861712     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971015)80:8+<1572::aid-cncr7>3.0.co;2-m     Document Type: Conference Paper

References (67)

1. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer 1987;55:61-6.
2. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-2.
3. Aaron AD. The management of cancer metastatic to bone. JAMA 1994;272(15):1206-9.
4. Weiss L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin Exp Metastasis 1992;10:191-9.
5. Cifuentes N, Pickren JW. Metastases from carcinoma of mammary gland: an autopsy study. J Surg Oncol 1979;11: 193-205.
6. Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR. Scanning electron microscopy in bone pathology: review of methods. Potential and applications. Scanning Electr Microsc 1986;IV:1537-54.
7. Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 1994;15(2):161-6.
8. Francini G, Petrioli R, Maioli E, Gonnelli S, Marsili S, Aquino A, et al. Hypercalcemia in breast cancer. Clin Exp Metastasis 1993;11:359-67.
9. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, et al. Localization of parathyroid hormone-related protein in breast cancer metastasis: increased incidence in bone compared with other sites. Cancer Res 1991;51:3059-61.
10. Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM, et al. Localization of parathyroid hormone-related protein mRNA expression and metastatic lesions by in situ hybridization. J Bone Miner Res 1992;7(8):971-80.
11. Bouizar Z, Spyratos F, Deytieux S, de Vernejoul M, Jullienne A. Polymerase chain reaction analysis of parathyroid hormone-related protein gene expression in breast cancer patients and occurrence of bone metastases. Cancer Res 1993;53:5076-8.
12. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall REH, Kemp Be, Suva LJ, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987;84:5048-52.
13. Burtis WJ, Wu T, Bunch C, Wysolmerski J, Insogna K, Weir E, et al. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 1987;262(15):7151-6.
14. Strewler GJ, Stern P, Jacobs J, Eveloff J, Klein RF, Leung SC, et al. Parathyroid hormone-like protein from human renal carcinoma cells structural and functional homology with parathyroid hormone. J Clin Invest 1987;80:1803-7.
15. Suva LJ, Winslow GA, Wettenhall REH, Hammonds RG, Moseley JM, Dieffenbach-Jagger, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987;237:893-6.
16. Abou-Samra A, Juppner H, Force T, Freeman MW, Kong X, Schipani E, et al. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 1992;89:2732-6.
17. Horiuchi N, Caulfield M, Fisher JE, Goldman M, Mckee R, Reagan J, et al. Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science 1987;238:1566-8.
18. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall REH, Stapleton D, et al. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 1987;238:1568-70.
19. Yates AJP, Gutierrez GE, Smolens P, Travis PS, Katz MS, Auftemorte TB, et al. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J Clin Invest 1988;81:932-8.
20. Sartori L, Weir EC, Stewart AF, Broadus AE, Mangin M, Barrett PQ, et al. Synthetic and partially-purified adenylate cyclase-stimulating proteins from tumors associated with humoral hypercalcemia of malignancy inhibit phosphate transport in a PTH-responsive renal cell line. J Clin Endocrinol Metab 1987;66:459-61.
21. Asa SL, Henderson J, Goltzman D, Drucker DJ. Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab 1990;71:1112-8.
22. Danks JA, Ebeling PR, Hayman J, Chou ST, Moseley JM, Dunlop J, et al. Parathyroid hormone-related protein: immunohistochemical localization in cancers and in normal skin. J Bone Miner Res 1989;4:273-8.
23. Burtis WJ, Bady TF, Orloff JJ, Ersbak JB, Warrell RP, Olson BR, et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 1990; 322:1106-12.
24. Kremer R, Karaplis AC, Henderson J, Gulliver W, Banville D, Hendy GN, et al. Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. J Clin Invest 1991;87:884-93.
25. Sebag M, Henderson J, Goltzman D, Kremer R. Regulation of parathyroid hormone-related peptide production in normal human mammary epithelial cells in vitro. Am J Physiol 1992;267:C723-30.
26. Ferrari SL, Rizzoli R, Bonjour J-P. Effects of epidermal growth factor on parathyroid hormone-related protein production by mammary epithelial cells. J Bone Miner Res 1994;9:639-44.
27. Southby J, Murphy LM, Martin TJ, Gillespie MT. Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein. Endocrinology 1996;137:1349-57.
28. Rizzoli R, Feyen JHM, Grau G, Wohlwend A, Sappino AP, Bonjour J-Ph. Regulation of parathyroid hormone-related protein production in a human lung squamous cell carcinoma line. J Endocrinol 1994;143:333-41.
29. Burton PBJ, Knight DE. Parathyroid hormone-related peptide can regulate growth of human lung cancer cells. FEBS Lett 1992;305:228-32.
30. Zakalik D, Diep D, Hooks MA, Nissenson RA, Strewler GJ. Transforming growth factor β increases stability of parathyroid hormone-related protein messenger RNA. J Bone Miner Res 1992;7(Suppl 1):104A, S118.
31. Merryman JI, DeWille JW, Werkmeister JR, Capen CC, Rosol TJ. Effects of transforming growth factor-β on parathyroid hormone-related protein production and ribonucleic acid expression by a squamous carcinoma cell line in vitro. Endocrinology 1994; 134:2424-30.
32. Kiriyama T, Gillespie MT, Glatz JA, Fukumoto S, Moseley JM, Martin TJ. Transforming growth factor β stimulation of parathyroid hormone-related protein (PTHrP): a paracrine regulator? Mol Cell Endocrinol 1992;92:55-62.
33. Li X, Drucker DJ. Parathyroid hormone-related peptide is a downstream target for ras and src activation. J Biol Chem 1994;269(9):6263-6.
34. Theide MA. The mRNA encoding a parathyroid hormone-like peptide is produced in mammary tissue in response to elevations in serum prolactin. Mol Endocrinol 1989;3:1443-7.
35. Pirola CJ, Wang H-M, Kamyar A, Wu S, Enomoto H, Sharifi B, et al. Angiotensin II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through both transcriptional and posttranscriptional mechanisms. J Biol Chem 1993;268:1987-94.
36. Glatz JA, Heath JK, Southby J, O'Keeffe LM, Kiriyama T, Moseley JM, et al. Dexamethasone regulation of parathyroid hormone-related protein (PTHrP) expression in a squamous cancer cell line. Mol Cell Endocrinol 1994;101:295-306.
37. Lu C, Ikeda K, Deftos LJ, Gazdar AF, Mangin M, Broadus AE. Glucocorticoid regulation of parathyroid hormone-related peptide gene transcription in a human neuroendocrine cell line. Mol Endocrinol 1989;3(12):2034-40.
38. Wysolmerski JJ, McCaughem-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 1995;121(11):3539-47.
39. Southby J, Kissin MW, Danks JA, Hayman JA, Moseley JM, Henderson MA, et al. Immunohistochemical localization of parathyroid hormone-related protein in breast cancer. Cancer Res 1990;50:7710-6.
40. Liapis H, Crouch EC, Grosso LE, Kitazawa S, Wick MR. Expression of parathyroid like protein in normal, proliferative and neoplastic human breast tissue. Am J Pathol 1993; 143(4):1169-78.
41. Bundred NJ, Walker RA, Ratcliffe WA, Warwick J, Morrison JM, Ratcliffe JG. Parathyroid hormone related protein and skeletal morbidity in breast cancer. Eur J Cancer 1992;28(2-3):690-2.
42. Bundred NJ, Ratcliffe WA, Walker RA, Cjoley S, Morrison JM, Ratcliffe JG. Parathyroid hormone related protein and hypercalcaemia in breast cancer. BMJ 1991;303(6816):1506-9.
43. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, et al. Parathyroid hormone-related protein; elevated levels in both humoral hypercalcemia and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 1991;73:1309-15.
44. Arguello F, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988;48:6878-81.
45. Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, et al. The bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 1995;55:3551-7.
46. Cailleau R, Yong R, Olive M, Reeves WJ. Breast tumor cell lines from pleural effusions. J Natl Cancer Inst 1974;53:661-74.
47. Guise TA, Taylor SD, Yoneda T, Sasaki A, Wright K, Boyce BF, et al. PTHrP expression by breast cancer cells enhance osteolytic bone metastases in vivo. J Bone Miner Res 1994;9(Suppl 1):33, S128.
48. Guise TA, Yin JJ, Taylor SD, Kumagai Y, Dallas M, Boyce BF, et al. Evidence for a causal role of parathyroid hormone-related protein in breast cancer-mediated osteolysis. J Clin Invest 1996;98(7):1544-8.
49. Yin JJ, Taylor SD, Yoneda T, Dallas M, Boyce BF, Kumagai Y, et al. Evidence that parathyroid hormone-related protein (PTHrP) causes osteolytic metastases without hypercalcemia [abstract]. J Bone Miner Res 1995;10(Suppl 1):S169-22.
50. Hauschka PV, Mavrakos AE, Iafrati MD, Doleman SE, Klagsbrun M. Growth factors in bone matrix. J Biol Chem 1986;261:12665-74.
51. Pfeilschifter J, Mundy GR. Modulation of transforming growth factor β activity in bone cultures by osteotropic hormones. Proc Natl Acad Sci USA 1987;84:2024-8.
52. DeLaMata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR, et al. IL-6 enhances hypercalcemia and bone resorption mediated by PTHrP in vivo. J Clin Invest 1995;95:2846-52.
53. Glover D, Lipton A, Keller A, Miller AA, Browning S, Fram RJ, et al. Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. Cancer 1994;74(11):2949-55.
54. van Holten-Verzantvoort AT, Bijvoet OLM, Hermans J, Harinck HIJ, Elte JWF, Beex LVAM, et al. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet 1987;983-5.
55. Grutters JC, Hermus ARMM, de Mulder PHM, Beex LVAM. Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphonate (APD). Breast Cancer Res Treat 1993;25:277-81.
56. Paterson AHG, Ernst DS, Powles TJ, Ashley S, McMloskey EV, Kanis J. Treatment of skeletal disease in breast cancer with clodronate. Bone 1991;2(Suppl 1):S25-S30.
57. Morton AR, Cantrill JA, Pilliai GV, McMahon A, Anderson DC, Howell A. Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. BMJ 1988;297:772-3.
58. Paterson AH, Powles TJ, Kanis JA, McCloskey E, Hanson J, Ashley S. Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 1993;11:59-65.
59. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, et al. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 1996;335(24):1785-91.
60. Hall DG, Stoica G. Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system. J Bone Miner Res 1994;9:221-30.
61. Herman ME, Katzenellenbogen BS. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth. Cancer Res 1994;54:5867-74.
62. van Roozendaal CEP, Klijn JGM, van Ooijen B, Claassen C, Eggermont AMM, Henzen-Logmans SC, et al. Transforming growth factor beta secretion form primary breast cancer fibroblasts. Mol Cell Endocrinol 1995;111:1-6.
63. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor β gene family members and bone. Endocr Rev 1994;15:27-39.
64. Derynck R. TGF-β-receptor-mediated signaling. Trends Biochem Sci 1994;19:548-53.
65. Wieser R, Attisano L, Wrana JL, Massagué J. Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region. Mol Cell Biol 1993;13:7239-47.
66. Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of the TGF-β receptor. Nature 1994;370:341-7.
67. Yin JJ, Taylor SD, Dallas M, Massagué J, Mundy GR, Guise TA. Dominant negative blockade of the transforming growth factor β type II receptor decreases breast cancer-mediated osteolysis [abstract]. J Bone Miner Res 1996;11(Suppl 1):S139-180.